Lu-shan Xiao

Development and Validation of a Deep Learning-Based Model Using Computed Tomography Imaging for Predicting Disease Severity of Coronavirus Disease 2019

Lu-shan Xiao, Pu Li, Fenglong Sun, 2020, Frontiers in Bioengineering and Biotechnology.

A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer

Dan Zou, Lu-shan Xiao, Jie Peng, 2022, Frontiers in Medicine.

Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice

Jian-Guo Zhou, Dehua Wu, Lu-shan Xiao, 2022, BMC Medicine.

Clinical Characteristics of Patients With Progressive and Non-progressive Coronavirus Disease 2019: Evidence From 365 Hospitalised Patients in Honghu and Nanchang, China

Lu-shan Xiao, Pu Li, Yan-pei Zhang, 2020, Frontiers in Medicine.